Zhejiang Meihua Dingchang Pharmaceutical

Founded in 2011，MHDC focus on the research and development of novel pharmaceutical drugs, and manufacture of high-difficulty drug dosage forms and medical devices. Up to now, the company's core business has expanded to the R&D and manufacture of Microsphere/Microcrystal, Solid Extended-Release Drugs, Extended-Release Injectables, Class-1 Medical Devices and new drugs, including minocycline hydrochloride ER tablets, exenatide/liraglttide ER microspheres, proteasome inhibitors, anti-tumor innovative drugs, nasal dressings and other products. The company is positioned as a R & D enterprise. While adhering to the independent research and development of the core pipeline, it uses its own unique ...